0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bioresorbable Drug-Eluting Stents Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-12H14457
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Bioresorbable Drug Eluting Stents Market Research Report 2023
BUY CHAPTERS

Global Bioresorbable Drug-Eluting Stents Market Research Report 2025

Code: QYRE-Auto-12H14457
Report
February 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bioresorbable Drug-Eluting Stents Market Size

The global market for Bioresorbable Drug-Eluting Stents was valued at US$ 479 million in the year 2024 and is projected to reach a revised size of US$ 1065 million by 2031, growing at a CAGR of 12.3% during the forecast period.

Bioresorbable Drug-Eluting Stents Market

Bioresorbable Drug-Eluting Stents Market

The bioabsorbable drug-eluting stent consists of a stent and a delivery system. The stent consists of three parts: a stent matrix, a developing marker, and a drug carrier coating. It is used to treat intravascular stenosis in patients with primary coronary atherosclerosis, improve coronary blood flow and prevent restenosis.
Biodegradable stents are the development direction of coronary stents, which can solve the pain point of permanent foreign bodies in drug-eluting metal stents. Cardiac stents are mainly used in the treatment of coronary heart disease. Coronary interventional therapy (PCI) has experienced three generations of technical development: relay balloon dilatation, bare metal stent (BMS) and drug-eluting stent (DES). At present, most of the stents used in the world are the third-generation stents - drug-eluting stents. Since their materials are metal, metal foreign bodies will permanently remain in the human body after implantation. The material of the degradable stent is polylactic acid, etc., which can be completely degraded within 2-3 years after implantation, and can restore the function and elasticity of blood vessels without permanent retention, so it is considered the fourth revolution in the treatment of coronary heart disease.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bioresorbable Drug-Eluting Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioresorbable Drug-Eluting Stents.
The Bioresorbable Drug-Eluting Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bioresorbable Drug-Eluting Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioresorbable Drug-Eluting Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bioresorbable Drug-Eluting Stents Market Report

Report Metric Details
Report Name Bioresorbable Drug-Eluting Stents Market
Accounted market size in year US$ 479 million
Forecasted market size in 2031 US$ 1065 million
CAGR 12.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Metal Base Stent
  • Polymer Stent
Segment by Application
  • Hospital
  • Specialty Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Boston Scientific, Biotronik, Shanghai Bioheart Biological Technology, LifeTech Scientific, Lepu Medical Technology, Microport, Shandong Huaan Biotechnology, Shenzhen Salubris Biomedical Engineering, Beijing Advanced Medical Technologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bioresorbable Drug-Eluting Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bioresorbable Drug-Eluting Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Bioresorbable Drug-Eluting Stents Market growing?

Ans: The Bioresorbable Drug-Eluting Stents Market witnessing a CAGR of 12.3% during the forecast period 2025-2031.

What is the Bioresorbable Drug-Eluting Stents Market size in 2031?

Ans: The Bioresorbable Drug-Eluting Stents Market size in 2031 will be US$ 1065 million.

Who are the main players in the Bioresorbable Drug-Eluting Stents Market report?

Ans: The main players in the Bioresorbable Drug-Eluting Stents Market are Abbott, Boston Scientific, Biotronik, Shanghai Bioheart Biological Technology, LifeTech Scientific, Lepu Medical Technology, Microport, Shandong Huaan Biotechnology, Shenzhen Salubris Biomedical Engineering, Beijing Advanced Medical Technologies

What are the Application segmentation covered in the Bioresorbable Drug-Eluting Stents Market report?

Ans: The Applications covered in the Bioresorbable Drug-Eluting Stents Market report are Hospital, Specialty Clinic

What are the Type segmentation covered in the Bioresorbable Drug-Eluting Stents Market report?

Ans: The Types covered in the Bioresorbable Drug-Eluting Stents Market report are Metal Base Stent, Polymer Stent

1 Bioresorbable Drug-Eluting Stents Market Overview
1.1 Product Definition
1.2 Bioresorbable Drug-Eluting Stents by Type
1.2.1 Global Bioresorbable Drug-Eluting Stents Market Value Comparison by Type (2024 VS 2031)
1.2.2 Metal Base Stent
1.2.3 Polymer Stent
1.3 Bioresorbable Drug-Eluting Stents by Application
1.3.1 Global Bioresorbable Drug-Eluting Stents Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Specialty Clinic
1.4 Global Bioresorbable Drug-Eluting Stents Market Size Estimates and Forecasts
1.4.1 Global Bioresorbable Drug-Eluting Stents Revenue 2020-2031
1.4.2 Global Bioresorbable Drug-Eluting Stents Sales 2020-2031
1.4.3 Global Bioresorbable Drug-Eluting Stents Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bioresorbable Drug-Eluting Stents Market Competition by Manufacturers
2.1 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bioresorbable Drug-Eluting Stents Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bioresorbable Drug-Eluting Stents, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bioresorbable Drug-Eluting Stents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bioresorbable Drug-Eluting Stents, Product Type & Application
2.7 Global Key Manufacturers of Bioresorbable Drug-Eluting Stents, Date of Enter into This Industry
2.8 Global Bioresorbable Drug-Eluting Stents Market Competitive Situation and Trends
2.8.1 Global Bioresorbable Drug-Eluting Stents Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bioresorbable Drug-Eluting Stents Players Market Share by Revenue
2.8.3 Global Bioresorbable Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bioresorbable Drug-Eluting Stents Market Scenario by Region
3.1 Global Bioresorbable Drug-Eluting Stents Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bioresorbable Drug-Eluting Stents Sales by Region: 2020-2031
3.2.1 Global Bioresorbable Drug-Eluting Stents Sales by Region: 2020-2025
3.2.2 Global Bioresorbable Drug-Eluting Stents Sales by Region: 2026-2031
3.3 Global Bioresorbable Drug-Eluting Stents Revenue by Region: 2020-2031
3.3.1 Global Bioresorbable Drug-Eluting Stents Revenue by Region: 2020-2025
3.3.2 Global Bioresorbable Drug-Eluting Stents Revenue by Region: 2026-2031
3.4 North America Bioresorbable Drug-Eluting Stents Market Facts & Figures by Country
3.4.1 North America Bioresorbable Drug-Eluting Stents Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bioresorbable Drug-Eluting Stents Sales by Country (2020-2031)
3.4.3 North America Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bioresorbable Drug-Eluting Stents Market Facts & Figures by Country
3.5.1 Europe Bioresorbable Drug-Eluting Stents Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bioresorbable Drug-Eluting Stents Sales by Country (2020-2031)
3.5.3 Europe Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bioresorbable Drug-Eluting Stents Market Facts & Figures by Region
3.6.1 Asia Pacific Bioresorbable Drug-Eluting Stents Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bioresorbable Drug-Eluting Stents Sales by Region (2020-2031)
3.6.3 Asia Pacific Bioresorbable Drug-Eluting Stents Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bioresorbable Drug-Eluting Stents Market Facts & Figures by Country
3.7.1 Latin America Bioresorbable Drug-Eluting Stents Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bioresorbable Drug-Eluting Stents Sales by Country (2020-2031)
3.7.3 Latin America Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bioresorbable Drug-Eluting Stents Market Facts & Figures by Country
3.8.1 Middle East and Africa Bioresorbable Drug-Eluting Stents Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bioresorbable Drug-Eluting Stents Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bioresorbable Drug-Eluting Stents Sales by Type (2020-2031)
4.1.1 Global Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025)
4.1.2 Global Bioresorbable Drug-Eluting Stents Sales by Type (2026-2031)
4.1.3 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2020-2031)
4.2 Global Bioresorbable Drug-Eluting Stents Revenue by Type (2020-2031)
4.2.1 Global Bioresorbable Drug-Eluting Stents Revenue by Type (2020-2025)
4.2.2 Global Bioresorbable Drug-Eluting Stents Revenue by Type (2026-2031)
4.2.3 Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Type (2020-2031)
4.3 Global Bioresorbable Drug-Eluting Stents Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bioresorbable Drug-Eluting Stents Sales by Application (2020-2031)
5.1.1 Global Bioresorbable Drug-Eluting Stents Sales by Application (2020-2025)
5.1.2 Global Bioresorbable Drug-Eluting Stents Sales by Application (2026-2031)
5.1.3 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2020-2031)
5.2 Global Bioresorbable Drug-Eluting Stents Revenue by Application (2020-2031)
5.2.1 Global Bioresorbable Drug-Eluting Stents Revenue by Application (2020-2025)
5.2.2 Global Bioresorbable Drug-Eluting Stents Revenue by Application (2026-2031)
5.2.3 Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Application (2020-2031)
5.3 Global Bioresorbable Drug-Eluting Stents Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Bioresorbable Drug-Eluting Stents Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Company Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boston Scientific Bioresorbable Drug-Eluting Stents Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 Biotronik
6.3.1 Biotronik Company Information
6.3.2 Biotronik Description and Business Overview
6.3.3 Biotronik Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biotronik Bioresorbable Drug-Eluting Stents Product Portfolio
6.3.5 Biotronik Recent Developments/Updates
6.4 Shanghai Bioheart Biological Technology
6.4.1 Shanghai Bioheart Biological Technology Company Information
6.4.2 Shanghai Bioheart Biological Technology Description and Business Overview
6.4.3 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product Portfolio
6.4.5 Shanghai Bioheart Biological Technology Recent Developments/Updates
6.5 LifeTech Scientific
6.5.1 LifeTech Scientific Company Information
6.5.2 LifeTech Scientific Description and Business Overview
6.5.3 LifeTech Scientific Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.5.4 LifeTech Scientific Bioresorbable Drug-Eluting Stents Product Portfolio
6.5.5 LifeTech Scientific Recent Developments/Updates
6.6 Lepu Medical Technology
6.6.1 Lepu Medical Technology Company Information
6.6.2 Lepu Medical Technology Description and Business Overview
6.6.3 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product Portfolio
6.6.5 Lepu Medical Technology Recent Developments/Updates
6.7 Microport
6.7.1 Microport Company Information
6.7.2 Microport Description and Business Overview
6.7.3 Microport Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Microport Bioresorbable Drug-Eluting Stents Product Portfolio
6.7.5 Microport Recent Developments/Updates
6.8 Shandong Huaan Biotechnology
6.8.1 Shandong Huaan Biotechnology Company Information
6.8.2 Shandong Huaan Biotechnology Description and Business Overview
6.8.3 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product Portfolio
6.8.5 Shandong Huaan Biotechnology Recent Developments/Updates
6.9 Shenzhen Salubris Biomedical Engineering
6.9.1 Shenzhen Salubris Biomedical Engineering Company Information
6.9.2 Shenzhen Salubris Biomedical Engineering Description and Business Overview
6.9.3 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product Portfolio
6.9.5 Shenzhen Salubris Biomedical Engineering Recent Developments/Updates
6.10 Beijing Advanced Medical Technologies
6.10.1 Beijing Advanced Medical Technologies Company Information
6.10.2 Beijing Advanced Medical Technologies Description and Business Overview
6.10.3 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product Portfolio
6.10.5 Beijing Advanced Medical Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bioresorbable Drug-Eluting Stents Industry Chain Analysis
7.2 Bioresorbable Drug-Eluting Stents Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bioresorbable Drug-Eluting Stents Production Mode & Process Analysis
7.4 Bioresorbable Drug-Eluting Stents Sales and Marketing
7.4.1 Bioresorbable Drug-Eluting Stents Sales Channels
7.4.2 Bioresorbable Drug-Eluting Stents Distributors
7.5 Bioresorbable Drug-Eluting Stents Customer Analysis
8 Bioresorbable Drug-Eluting Stents Market Dynamics
8.1 Bioresorbable Drug-Eluting Stents Industry Trends
8.2 Bioresorbable Drug-Eluting Stents Market Drivers
8.3 Bioresorbable Drug-Eluting Stents Market Challenges
8.4 Bioresorbable Drug-Eluting Stents Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Bioresorbable Drug-Eluting Stents Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Bioresorbable Drug-Eluting Stents Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Bioresorbable Drug-Eluting Stents Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Bioresorbable Drug-Eluting Stents Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Bioresorbable Drug-Eluting Stents Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Bioresorbable Drug-Eluting Stents Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Bioresorbable Drug-Eluting Stents Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Bioresorbable Drug-Eluting Stents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Bioresorbable Drug-Eluting Stents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Bioresorbable Drug-Eluting Stents, Product Type & Application
 Table 12. Global Key Manufacturers of Bioresorbable Drug-Eluting Stents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bioresorbable Drug-Eluting Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioresorbable Drug-Eluting Stents as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bioresorbable Drug-Eluting Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Bioresorbable Drug-Eluting Stents Sales by Region (2020-2025) & (K Units)
 Table 18. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2020-2025)
 Table 19. Global Bioresorbable Drug-Eluting Stents Sales by Region (2026-2031) & (K Units)
 Table 20. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2026-2031)
 Table 21. Global Bioresorbable Drug-Eluting Stents Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Region (2020-2025)
 Table 23. Global Bioresorbable Drug-Eluting Stents Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Region (2026-2031)
 Table 25. North America Bioresorbable Drug-Eluting Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) & (K Units)
 Table 27. North America Bioresorbable Drug-Eluting Stents Sales by Country (2026-2031) & (K Units)
 Table 28. North America Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Bioresorbable Drug-Eluting Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Bioresorbable Drug-Eluting Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Bioresorbable Drug-Eluting Stents Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Bioresorbable Drug-Eluting Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Bioresorbable Drug-Eluting Stents Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Bioresorbable Drug-Eluting Stents Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Bioresorbable Drug-Eluting Stents Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Bioresorbable Drug-Eluting Stents Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Bioresorbable Drug-Eluting Stents Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bioresorbable Drug-Eluting Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Bioresorbable Drug-Eluting Stents Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bioresorbable Drug-Eluting Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Bioresorbable Drug-Eluting Stents Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Bioresorbable Drug-Eluting Stents Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Type (2020-2025)
 Table 51. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Type (2026-2031)
 Table 52. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2020-2025)
 Table 53. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2026-2031)
 Table 54. Global Bioresorbable Drug-Eluting Stents Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Bioresorbable Drug-Eluting Stents Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Type (2020-2025)
 Table 57. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Type (2026-2031)
 Table 58. Global Bioresorbable Drug-Eluting Stents Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Bioresorbable Drug-Eluting Stents Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Application (2020-2025)
 Table 61. Global Bioresorbable Drug-Eluting Stents Sales (K Units) by Application (2026-2031)
 Table 62. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2020-2025)
 Table 63. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2026-2031)
 Table 64. Global Bioresorbable Drug-Eluting Stents Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Bioresorbable Drug-Eluting Stents Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Application (2020-2025)
 Table 67. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Application (2026-2031)
 Table 68. Global Bioresorbable Drug-Eluting Stents Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Bioresorbable Drug-Eluting Stents Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Bioresorbable Drug-Eluting Stents Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Boston Scientific Company Information
 Table 76. Boston Scientific Description and Business Overview
 Table 77. Boston Scientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boston Scientific Bioresorbable Drug-Eluting Stents Product
 Table 79. Boston Scientific Recent Developments/Updates
 Table 80. Biotronik Company Information
 Table 81. Biotronik Description and Business Overview
 Table 82. Biotronik Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Biotronik Bioresorbable Drug-Eluting Stents Product
 Table 84. Biotronik Recent Developments/Updates
 Table 85. Shanghai Bioheart Biological Technology Company Information
 Table 86. Shanghai Bioheart Biological Technology Description and Business Overview
 Table 87. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product
 Table 89. Shanghai Bioheart Biological Technology Recent Developments/Updates
 Table 90. LifeTech Scientific Company Information
 Table 91. LifeTech Scientific Description and Business Overview
 Table 92. LifeTech Scientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. LifeTech Scientific Bioresorbable Drug-Eluting Stents Product
 Table 94. LifeTech Scientific Recent Developments/Updates
 Table 95. Lepu Medical Technology Company Information
 Table 96. Lepu Medical Technology Description and Business Overview
 Table 97. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product
 Table 99. Lepu Medical Technology Recent Developments/Updates
 Table 100. Microport Company Information
 Table 101. Microport Description and Business Overview
 Table 102. Microport Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Microport Bioresorbable Drug-Eluting Stents Product
 Table 104. Microport Recent Developments/Updates
 Table 105. Shandong Huaan Biotechnology Company Information
 Table 106. Shandong Huaan Biotechnology Description and Business Overview
 Table 107. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product
 Table 109. Shandong Huaan Biotechnology Recent Developments/Updates
 Table 110. Shenzhen Salubris Biomedical Engineering Company Information
 Table 111. Shenzhen Salubris Biomedical Engineering Description and Business Overview
 Table 112. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product
 Table 114. Shenzhen Salubris Biomedical Engineering Recent Developments/Updates
 Table 115. Beijing Advanced Medical Technologies Company Information
 Table 116. Beijing Advanced Medical Technologies Description and Business Overview
 Table 117. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product
 Table 119. Beijing Advanced Medical Technologies Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Bioresorbable Drug-Eluting Stents Distributors List
 Table 123. Bioresorbable Drug-Eluting Stents Customers List
 Table 124. Bioresorbable Drug-Eluting Stents Market Trends
 Table 125. Bioresorbable Drug-Eluting Stents Market Drivers
 Table 126. Bioresorbable Drug-Eluting Stents Market Challenges
 Table 127. Bioresorbable Drug-Eluting Stents Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bioresorbable Drug-Eluting Stents
 Figure 2. Global Bioresorbable Drug-Eluting Stents Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bioresorbable Drug-Eluting Stents Market Share by Type: 2024 & 2031
 Figure 4. Metal Base Stent Product Picture
 Figure 5. Polymer Stent Product Picture
 Figure 6. Global Bioresorbable Drug-Eluting Stents Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Bioresorbable Drug-Eluting Stents Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Specialty Clinic
 Figure 10. Global Bioresorbable Drug-Eluting Stents Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Bioresorbable Drug-Eluting Stents Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Bioresorbable Drug-Eluting Stents Sales (2020-2031) & (K Units)
 Figure 13. Global Bioresorbable Drug-Eluting Stents Average Price (US$/Unit) & (2020-2031)
 Figure 14. Bioresorbable Drug-Eluting Stents Report Years Considered
 Figure 15. Bioresorbable Drug-Eluting Stents Sales Share by Manufacturers in 2024
 Figure 16. Global Bioresorbable Drug-Eluting Stents Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Bioresorbable Drug-Eluting Stents Players: Market Share by Revenue in Bioresorbable Drug-Eluting Stents in 2024
 Figure 18. Bioresorbable Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Bioresorbable Drug-Eluting Stents Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2020-2031)
 Figure 21. North America Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2020-2031)
 Figure 22. United States Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2020-2031)
 Figure 25. Europe Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Bioresorbable Drug-Eluting Stents Revenue Market Share by Region (2020-2031)
 Figure 33. China Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Bioresorbable Drug-Eluting Stents Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Bioresorbable Drug-Eluting Stents by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Bioresorbable Drug-Eluting Stents by Type (2020-2031)
 Figure 52. Global Bioresorbable Drug-Eluting Stents Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Bioresorbable Drug-Eluting Stents by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Bioresorbable Drug-Eluting Stents by Application (2020-2031)
 Figure 55. Global Bioresorbable Drug-Eluting Stents Price (US$/Unit) by Application (2020-2031)
 Figure 56. Bioresorbable Drug-Eluting Stents Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Cardiovascular Informations (CVIS) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10A6248
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Pulmonary Arterial Hypertension (PAH) Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8I7059
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Heparin Calcium Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15Y8668
Wed Sep 10 00:00:00 UTC 2025

Add to Cart